SWI/SNF complex

SWI/SNF complex
Name	SWI/SNF complex
Caption	ATP-dependent chromatin-remodeling complex
Organism	Eukaryotes
Type	Multiprotein chromatin remodeler
Function	Nucleosome sliding, eviction, histone exchange

SWI/SNF complex The SWI/SNF complex is an ATP-dependent chromatin-remodeling assembly that mobilizes nucleosomes to regulate transcription, DNA repair, and replication. First characterized in Saccharomyces cerevisiae, it has conserved counterparts in Homo sapiens, Drosophila melanogaster, and plants, and interacts genetically and biochemically with factors characterized in studies of Gregor Mendel, Charles Darwin, James Watson, and Francis Crick-era chromatin biology. The complex connects signaling pathways studied in contexts such as Cell Press-published pathways and work involving Howard Hughes Medical Institute investigators to epigenetic regulation implicated in prominent projects like the Human Genome Project and initiatives at institutions including Broad Institute and National Institutes of Health.

Overview

SWI/SNF assemblies were discovered through genetic screens in Saccharomyces cerevisiae for regulators of mating-type switching and sucrose fermentation, linking to landmark research by laboratories associated with Cold Spring Harbor Laboratory, University of California, Berkeley, and Massachusetts Institute of Technology. Homologous complexes—BAF and PBAF in mammals—have been studied in contexts spanning developmental programs analyzed at Harvard University, Stanford University, and University of Cambridge, and in disease cohorts investigated by consortia such as The Cancer Genome Atlas and International Cancer Genome Consortium. SWI/SNF remodelers integrate signals from kinases like MAPK, CDK7, and AKT1 and transcription factors such as TP53, MYC, and SOX2, and have been linked to pathways explored in research at European Molecular Biology Laboratory, Max Planck Society, and Wellcome Trust-funded centers.

Composition and Subunit Architecture

Eukaryotic SWI/SNF assemblies are modular, comprising an ATPase core related to the SNF2 family and accessory subunits homologous to mammalian SMARCA4 (BRG1) or SMARCA2 (BRM), with scaffold proteins like SMARCB1 (SNF5/INI1), ARID1A (BAF250A), and PBRM1 (BAF180) in PBAF variants. Combinatorial incorporation of subunits yields complexes analogous to those studied in model systems such as Mus musculus, Xenopus laevis, and Arabidopsis thaliana. Structural modules parallel domains characterized in proteins like BRD4, CBP, EP300, and HDAC1, and share regulatory motifs studied in literature from laboratories at Yale University and Johns Hopkins University. Mass spectrometry-based proteomics from centers like ProteomeXchange and EMBL-EBI has cataloged subunit stoichiometry, while human genetics consortia including ClinVar and gnomAD annotate variant frequencies in subunit genes.

Mechanism of Chromatin Remodeling

ATP hydrolysis by the SNF2-family ATPase drives DNA translocation and nucleosome repositioning, a mechanism elucidated alongside studies of RNA polymerase II, TATA-binding protein, and elongation factors characterized by groups at Rockefeller University and Columbia University. Remodeling outcomes include nucleosome sliding, eviction, and histone variant exchange (e.g., H2A.Z), intersecting processes investigated in studies of DNA replication, DNA repair, and transcriptional regulation in projects from European Research Council and national facilities like Riken. Cryo-EM and biochemical reconstitution studies from teams at University of Oxford and ETH Zurich have resolved ATPase–nucleosome interactions comparable to mechanistic work on motors like helicases and complexes such as SWI/SNF-analogous remodelers in Tetrahymena thermophila.

Regulation and Post-translational Modifications

SWI/SNF function is modulated by phosphorylation by kinases including CHK1, ATM, and ATR; acetylation by enzymes such as CBP/EP300; ubiquitination pathways involving MDM2 and proteasomal regulators studied at Salk Institute; and methylation readers like SETD2 and EZH2 within Polycomb-related contexts. Interactions with chromatin marks studied in landmark projects including work from Broad Institute link SWI/SNF recruitment to enhancers characterized by factors like Mediator and pioneer factors such as FOXG1 and PU.1. Regulation also encompasses noncoding RNA interactions documented in investigations at Cold Spring Harbor Laboratory and post-translational control intersecting signaling cascades explored by researchers at University of California, San Francisco and Imperial College London.

Roles in Development and Cellular Processes

Genetic and developmental studies implicate SWI/SNF complexes in lineage specification events studied in embryonic stem cells research at Whitehead Institute and organogenesis work at Karolinska Institutet and Monash University. SWI/SNF contributes to neural development linked to genes examined in studies from UCL Great Ormond Street Institute of Child Health and cardiac differentiation projects at Cleveland Clinic. Cellular processes influenced include cell cycle control via interactions with RB1 and E2F networks, senescence pathways explored in research by Shinya Yamanaka-related labs, and immunity programs akin to those studied at Centers for Disease Control and Prevention and immunology groups at Pasteur Institute.

Involvement in Disease and Cancer

Mutations in SWI/SNF subunits are frequent in cancers cataloged by The Cancer Genome Atlas and clinical studies at MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, and Dana-Farber Cancer Institute. Loss-of-function alterations in SMARCB1 drive rhabdoid tumors historically described in pediatric oncology literature, while recurrent mutations in ARID1A and PBRM1 are characteristic of ovarian clear cell carcinoma and renal cell carcinoma, respectively, investigated in trials at National Cancer Institute. Synthetic-lethality approaches targeting dependencies with inhibitors of EZH2, PARP1, and CDK family members have advanced through collaborations including Genentech, Pfizer, and academic consortia. Beyond oncology, SWI/SNF mutations contribute to neurodevelopmental disorders documented in clinical genetics centers like Boston Children’s Hospital and syndromes such as Coffin–Siris and Nicolaides–Baraitser.

Experimental Methods and Structural Studies

Biochemical purification strategies developed initially in labs at University of Geneva and University of Edinburgh use affinity capture and gradient fractionation, while high-resolution structures derive from cryo-electron microscopy at facilities such as European Synchrotron Radiation Facility and Max Planck Institute for Biochemistry. Crosslinking mass spectrometry and hydrogen–deuterium exchange studies have been applied by teams at University of California, San Diego and ETH Zurich to map dynamics; single-molecule assays from groups at IBM Research and optical-trapping work in biophysics hubs illuminate translocation mechanics. Genetic screens using CRISPR technology pioneered at Broad Institute and high-throughput sequencing platforms from Illumina enable functional annotation of subunits and disease-associated variants.

Category:Chromatin remodeling complexes